ArticleJournal of gynecologic oncology2023

Controversies in the treatment of advanced ovarian cancer in the PARP inhibitors era: a Delphi consensus.

Andrés Redondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.